Literature DB >> 25724874

Respiratory dysfunction in multiple sclerosis.

George E Tzelepis1, F Dennis McCool2.   

Abstract

Respiratory dysfunction frequently occurs in patients with advanced multiple sclerosis (MS), and may manifest as acute or chronic respiratory failure, disordered control of breathing, respiratory muscle weakness, sleep disordered breathing, or neurogenic pulmonary edema. The underlying pathophysiology is related to demyelinating plaques involving the brain stem or spinal cord. Respiratory complications such as aspiration, lung infections and respiratory failure are typically seen in patients with long-standing MS. Acute respiratory failure is uncommon and due to newly appearing demyelinating plaques extensively involving areas of the brain stem or spinal cord. Early recognition of MS patients at risk for respiratory complications allows for the timely implementation of care and measures to decrease disease associated morbidity and mortality.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Multiple sclerosis; Respiration; Respiratory failure; Respiratory muscles

Mesh:

Year:  2015        PMID: 25724874     DOI: 10.1016/j.rmed.2015.01.018

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  7 in total

1.  Critical Illness in Patients with Multiple Sclerosis: A Matched Case-Control Study.

Authors:  Anush Karamyan; Martin W Dünser; Douglas J Wiebe; Georg Pilz; Peter Wipfler; Vaclav Chroust; Helmut F Novak; Larissa Hauer; Eugen Trinka; Johann Sellner
Journal:  PLoS One       Date:  2016-05-31       Impact factor: 3.240

Review 2.  Active Pulmonary Tuberculosis Triggered by Interferon Beta-1b Therapy of Multiple Sclerosis: Four Case Reports and a Literature Review.

Authors:  Carmen Adella Sirbu; Elena Dantes; Cristina Florentina Plesa; Any Docu Axelerad; Minerva Claudia Ghinescu
Journal:  Medicina (Kaunas)       Date:  2020-04-24       Impact factor: 2.430

3.  Comorbid disease burden among MS patients 1968-2012: A Swedish register-based cohort study.

Authors:  Kelsi A Smith; Sarah Burkill; Ayako Hiyoshi; Tomas Olsson; Shahram Bahmanyar; David Wormser; Yvonne Geissbühler; Alan Moore; Vineetkumar Kharat; Scott Montgomery
Journal:  Mult Scler       Date:  2020-03-12       Impact factor: 6.312

4.  Predicting Infection Risk in Multiple Sclerosis Patients Treated with Ocrelizumab: A Retrospective Cohort Study.

Authors:  Nabil Seery; Sifat Sharmin; Vivien Li; Ai-Lan Nguyen; Claire Meaton; Roberts Atvars; Nicola Taylor; Kelsey Tunnell; John Carey; Mark P Marriott; Katherine A Buzzard; Izanne Roos; Chris Dwyer; Josephine Baker; Lisa Taylor; Kymble Spriggs; Trevor J Kilpatrick; Tomas Kalincik; Mastura Monif
Journal:  CNS Drugs       Date:  2021-04-13       Impact factor: 5.749

Review 5.  Is there a role of pulmonary rehabilitation in extrapulmonary diseases frequently encountered in the practice of physical medicine and rehabilitation?

Authors:  Belma Füsun Köseoğlu
Journal:  Turk J Phys Med Rehabil       Date:  2022-06-01

6.  Pulmonary Function and Respiratory Muscle Strength in Patients with Multiple Sclerosis.

Authors:  Elisabeth Westerdahl; Martin Gunnarsson; Anna Wittrin; Ylva Nilsagård
Journal:  Mult Scler Int       Date:  2021-06-14

Review 7.  Practical approach to respiratory emergencies in neurological diseases.

Authors:  Fabrizio Racca; Andrea Vianello; Tiziana Mongini; Paolo Ruggeri; Antonio Versaci; Gian Luca Vita; Giuseppe Vita
Journal:  Neurol Sci       Date:  2019-12-02       Impact factor: 3.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.